Double-Action flu attack: new combo therapy trial aims to protect most vulnerable
NCT ID NCT04712539
Summary
This study is testing if giving two antiviral drugs together (baloxavir and oseltamivir) works better than the standard single drug (oseltamivir) to treat severe influenza. It is for people with blood cancers or who have had a stem cell transplant, as their weakened immune systems make flu more dangerous. Researchers will measure if the combination clears the virus faster and reduces serious complications like pneumonia or long hospital stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.